Ticker: HOWL

Company: Werewolf Therapeutics, Inc.

Person: LUKE EVNIN, director

Transaction date: May 13, 2026

Reporting date: May 13, 2026

Average share price: 0.54

Sold 44679.0 shares for 24126.66